5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.


Jan. 18

Weekly Gain

My Watchlist

Aurizon Mines (UNKNOWN: AZK.DL2  )




Pacific Biosciences (NASDAQ: PACB  )




Research In Motion (NASDAQ: BBRY  )




Genworth Financial (NYSE: GNW  )




Opko Health (NASDAQ: OPK  )




Source: Barron's.

Aurizon struck gold after receiving an unsolicited buyout offer. The gold producer, with projects in the Abitibi region of northwestern Quebec, announced on Friday that it formed a committee to explore the $792.6 million offer.

Pacific Biosciences of California continues to be one of the hottest stocks, up 76% so far this year and nearly tripling since bottoming out in November. There was no material news out on the DNA sequencing specialist this week, though momentum continues to linger since popping earlier this month, after a group including the FDA announced a new study based on Pacific Biosciences' technology.

Research In Motion continues to rally ahead of its Jan. 30 event for the big reveal of BlackBerry 10. There's a lot riding on the update to RIM's mobile operating system. As for news this past week, credit card issuing giant Visa approved RIM's mobile-payments solution.

Genworth Financial moved higher on a week where the news was largely mixed for financial companies. The wealth-management and financial-solutions provider moved on plans to separate its mortgage insurance business.

Opko Health hit a fresh 52-week high after its CEO continued his impressive string of share purchases. CEO Phillip Frost has now bought nearly $1.5 million worth of his company's stock this month. Opko also expanded its relationship with pharmaceuticals giant Bristol-Myers Squibb.

More winners for you
It was a great week for these five stocks, and now it's time to see which stocks will lead the way in the future. The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (4) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2205554, ~/Articles/ArticleHandler.aspx, 9/26/2016 6:44:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,094.83 -166.62 -0.91%
S&P 500 2,146.10 -18.59 -0.86%
NASD 5,257.49 -48.26 -0.91%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
AZK.DL2 $0.00 Down +0.00 +0.00%
Aurizon Mines Ltd.… CAPS Rating: **
BBRY $7.82 Down -0.09 -1.14%
BlackBerry CAPS Rating: *
GNW $4.82 Down -0.07 -1.43%
Genworth Financial CAPS Rating: ****
OPK $11.06 Down -0.03 -0.27%
Opko Health CAPS Rating: ***
PACB $9.22 Up +0.09 +0.99%
Pacific Bioscience… CAPS Rating: ***
BMY $55.48 Down -1.00 -1.77%
Bristol-Myers Squi… CAPS Rating: ****
V $81.81 Down -0.73 -0.88%
Visa CAPS Rating: *****